1. Home
  2. PDS vs CMPX Comparison

PDS vs CMPX Comparison

Compare PDS & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precision Drilling Corporation

PDS

Precision Drilling Corporation

HOLD

Current Price

$68.38

Market Cap

918.1M

Sector

N/A

ML Signal

HOLD

Logo Compass Therapeutics Inc.

CMPX

Compass Therapeutics Inc.

HOLD

Current Price

$5.08

Market Cap

752.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PDS
CMPX
Founded
1951
2014
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
918.1M
752.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PDS
CMPX
Price
$68.38
$5.08
Analyst Decision
Buy
Strong Buy
Analyst Count
2
10
Target Price
$98.00
$13.44
AVG Volume (30 Days)
76.5K
1.9M
Earning Date
10-22-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
2.98
N/A
Revenue
$1,316,232,437.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$2.89
N/A
P/E Ratio
$23.04
N/A
Revenue Growth
N/A
N/A
52 Week Low
$36.20
$1.33
52 Week High
$71.77
$5.86

Technical Indicators

Market Signals
Indicator
PDS
CMPX
Relative Strength Index (RSI) 67.77 52.34
Support Level $56.10 $5.09
Resistance Level $71.77 $5.44
Average True Range (ATR) 2.29 0.34
MACD 0.49 -0.07
Stochastic Oscillator 77.87 31.42

Price Performance

Historical Comparison
PDS
CMPX

About PDS Precision Drilling Corporation

Precision Drilling Corp is a provider of contract drilling and completion and production services to oil and natural gas exploration and production companies in Canada, the United States, and certain international locations. Contract Drilling Services include drilling rigs, procurement and distribution of oilfield supplies, and the manufacture, sale and repair of drilling equipment. Completion and Production Services include service rigs, oilfield equipment rental, and camp and catering services.

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.

Share on Social Networks: